Cargando…

Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019

BACKGROUND: The 2019 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report made recommendations for the assessment, initial and subsequent treatment chronic obstructive pulmonary disease (COPD) based on biomarkers, including blood eosinophil counts. METHODS: We evaluated the distribut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halpin, David M.G., de Jong, Hilda J.I., Carter, Victoria, Skinner, Derek, Price, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833455/ https://www.ncbi.nlm.nih.gov/pubmed/31709400 http://dx.doi.org/10.1016/j.eclinm.2019.07.003

Ejemplares similares

Diagnosing COPD
por: Halpin, David MG
Publicado: (2006)

ABCD of the phosphodiesterase family: interaction and differential activity in COPD
por: Halpin, David MG
Publicado: (2008)

Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal study
por: Halpin, David M.G., et al.
Publicado: (2023)

When is dual bronchodilation indicated in COPD?
por: Thomas, Mike, et al.
Publicado: (2017)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

From GOLD 0 to Pre-COPD
por: Han, MeiLan K., et al.
Publicado: (2021)

Meeting the GOLD Standard: COPD Treatment in the UK Today
por: Calverley, P.M.A.
Publicado: (2019)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD
por: Tse, Gary, et al.
Publicado: (2023)

Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis
por: Halpin, David MG, et al.
Publicado: (2015)

The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study
por: Jones, Rupert, et al.
Publicado: (2017)

Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey
por: Price, David, et al.
Publicado: (2018)

Mortality in COPD: Inevitable or Preventable? Insights from the Cardiovascular Arena
por: Halpin, David
Publicado: (2008)

Blood eosinophil count predicts treatment failure and hospital readmission for COPD
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
por: Halpin, David M. G., et al.
Publicado: (2016)

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
por: Brusselle, Guy, et al.
Publicado: (2015)

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
por: Halpin, David M.G., et al.
Publicado: (2018)

Management Of Community-Acquired Pneumonia: An Observational Study In UK Primary Care
por: Launders, Naomi, et al.
Publicado: (2019)

Preference for different relaxation techniques by COPD patients: comparison between six techniques
por: Hyland, Michael E, et al.
Publicado: (2016)

The stability of the ADO score among UK COPD patients from The Health Improvement Network
por: Keene, Spencer J., et al.
Publicado: (2020)

Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
por: Heatley, Heath, et al.
Publicado: (2023)

Cost–consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK
por: Wright, Antony, et al.
Publicado: (2022)

HOW APPROPRIATE IS THE GOLD STANDARD FOR DIAGNOSIS OF AIRWAY OBSTRUCTION?
por: Aggarwal, Ashutosh N.
Publicado: (2008)

Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trial
por: Dusser, Daniel, et al.
Publicado: (2016)

Audit on the appropriateness of integrated COPD management: the “ALT-BPCO” project
por: Nardini, Stefano, et al.
Publicado: (2014)

Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
por: Yawn, Barbara P, et al.
Publicado: (2016)

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial
por: Halpin, David M G, et al.
Publicado: (2022)

Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design
por: Worsley, Sally, et al.
Publicado: (2019)

A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD
por: Ming, Simon Wan Yau, et al.
Publicado: (2020)

First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis
por: Price, David, et al.
Publicado: (2016)

Interventions to improve screening and appropriate referral of patients with cancer for distress: systematic review protocol
por: McCarter, Kristen, et al.
Publicado: (2015)

Clinical Management of COPD in the Real World: Can Studies Reveal Errors in Management and Pathways to Improve Patient Care?
por: Halpin, David M G
Publicado: (2023)

Precision medicine in chronic obstructive pulmonary disease
por: Halpin, David M.G.
Publicado: (2022)

Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
por: Price, David, et al.
Publicado: (2014)

Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice
por: Hernández, Marcos, et al.
Publicado: (2018)

The IRYSS-COPD appropriateness study: objectives, methodology, and description of the prospective cohort
por: Quintana, José M, et al.
Publicado: (2011)

Asthma and COPD Patients’ Perception of Appropriate Metered-Dose Inhaler Technique
por: Ramadan, Wijdan H., et al.
Publicado: (2020)

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial
por: Ismaila, Afisi S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c4hjh2hto2orkm5mmgqqabjv3j